EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / SHS
Total 13F shares
7,746,847
Share change
+385,595
Total reported value
$76,681,000
Price per share
$9.90
Number of holders
37
Value change
+$3,831,369
Number of buys
15
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q2 2022

As of 30 Jun 2022, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,746,847 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., Hudson Bay Capital Management LP, D. E. Shaw & Co., Inc., 683 Capital Management, LLC, Altium Capital Management LP, CVI Holdings, LLC, GLAZER CAPITAL, LLC, Eisler Capital (UK) Ltd., and Saba Capital Management, L.P.. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.